Preclinical Molecular Imaging (PMI)
- Institution
- UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI
- Principal investigator
- Brian D. Ross
- Funding
- $162K
- Duration
- 1997–2028
Moonbase score
Still being scored
Abstract
The Preclinical Molecular Imaging Shared Resource (PMI-SR), previously called Preclinical Imaging and Computational Analysis, was established in 1986 and has been continuously funded by the Cancer Center Support Grant (CCSG) since 1988. To optimize growth and development, PMI-SR provides Rogel members access to state-of-the-art imaging instrumentation including positron emission tomography (PET), 3T and 7T magnetic resonance scanners, 3D and 4D computed tomography (CT) scanners, and bioluminescence/ fluorescence IVIS systems. Moreover, PMI-SR provides the indispensable scientific expertise to assist investigators with study design and interpretation of results. PMI-SR supports basic science studies along with proof of principle studies for eventual integration of imaging into clinical translational studies for further validation and to serve as companion diagnostics and predictive markers.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF MICHIGAN AT ANN ARBOR
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Michigan at Ann ArborNot yet scored
Development of quantitative bone marrow magnetic resonance imaging biomarkers to assess efficacy of novel molecularly targeted agents for myelofibrosis
Brian D. Ross · $647K · 2024–2029
- NIH · University of Michigan at Ann Arbor70
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial
Frederick Kofi Korley · $559K · 2020–2027
- NIH · University of Michigan at Ann Arbor64
Identification of Mild Cognitive Impairment using Machine Learning from Language and Behavior Markers
Hiroko Hayama Dodge · $733K · 2021–2027